Cancer Trials Ireland

🇮🇪Ireland

Country: 🇮🇪Ireland

Ownership: Private

Established: 1996-01-01

Employees: 11

Market Cap: -

Website: http://www.cancertrials.ie

Clinical Trials

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Phase 2

Completed

Conditions: Renal Cell Carcinoma

Interventions: Drug: Pazopanib

First Posted Date: 2012-03-29

Last Posted Date: 2021-12-23

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 43

Registration Number: NCT01566747

Locations: 🇮🇪
Beaumont Hospital, Dublin, Leinster, Ireland
🇮🇪
Mater Misericordiae University Hospital, Dublin, Leinster, Ireland
🇮🇪
Mater Private Hospital, Dublin, Leinster, Ireland

and more 6 locations

A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer

Phase 3

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Trastuzumab
Drug: Paclitaxel
Drug: Lapatinib

First Posted Date: 2012-02-03

Last Posted Date: 2023-04-06

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 75

Registration Number: NCT01526369

Locations: 🇫🇮
Helsinki University Hopsital, Helsinki, Finland
🇪🇸
Hospital Nuestra Senora de Sonsoles, Avila, Spain
🇪🇸
Hospital Clinico Universitario 'Lozano Blesa', Zaragoza, Spain

and more 31 locations

The Myocet/Lapatinib Study. ICORG 10-03, V5

Phase 1

Terminated

Conditions: Her2 Positive Metastatic Breast Cancer

Interventions: Drug: non-pegylated liposomal doxorubicon (Myocet™)
Drug: Lapatinib (Tyverb™)

First Posted Date: 2011-12-20

Last Posted Date: 2015-10-26

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 11

Registration Number: NCT01495884

Locations: 🇮🇪
University Hospital Limerick, Limerick, Ireland
🇮🇪
Bon Secours Hospital, Cork, Ireland
🇮🇪
St. Vincent's University Hospital, Dublin, Ireland

and more 7 locations

A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Docetaxel, Carboplatin, Trastuzumab and Lapatinib
Drug: Docetaxel, Carboplatin and Trastuzumab

First Posted Date: 2011-12-06

Last Posted Date: 2018-08-06

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 120

Registration Number: NCT01485926

Locations: 🇮🇪
Waterford Regional Hospital, Waterford, Ireland
🇮🇪
St James's Hospital, Dublin, Leinster, Ireland
🇮🇪
St Vincent's University Hospital, Dublin, Leinster, Ireland

and more 8 locations

Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Other: questionnaire administration
Procedure: quality-of-life assessment
Radiation: 3-dimensional conformal radiation therapy
Radiation: palliative radiation therapy
Radiation: whole-brain radiation therapy

First Posted Date: 2010-08-06

Last Posted Date: 2016-03-31

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 40

Registration Number: NCT01176487

Locations: 🇮🇪
St Luke's Radiation Oncology Network (SLRON), Dublin, Ireland
🇮🇪
Galway University Hospital, Galway, Ireland

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

Phase 2

Terminated

Conditions: Endometrial Cancer
Radiation Toxicity
Gastrointestinal Complications
Urinary Complications

Interventions: Radiation: 45 Gy/25 fractions

First Posted Date: 2010-07-16

Last Posted Date: 2023-04-06

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 92

Registration Number: NCT01164150

Locations: 🇮🇪
St Luke's Centre for Radiation Oncology at St Lukes Hospital, Dublin 6, Ireland
🇮🇪
Mid-Western Radiation Oncology Centre, Limerick, Ireland
🇮🇪
St Luke's Centre for Radiation Oncology at St James Hospital, Dublin 8, Ireland

and more 2 locations

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Completed

Conditions: Metastatic Cancer
Prostate Cancer

First Posted Date: 2010-07-12

Last Posted Date: 2020-11-17

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 73

Registration Number: NCT01160705

Locations: 🇮🇪
Beaumont Hospital, Dublin, Ireland
🇮🇪
Mater Private Hospital, Dublin, Ireland
🇮🇪
Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland

and more 2 locations

Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1

Withdrawn

Conditions: Lung Cancer

Interventions: Drug: cisplatin
Drug: etoposide phosphate
Drug: panobinostat
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2010-07-12

Last Posted Date: 2014-12-31

Lead Sponsor: Cancer Trials Ireland

Registration Number: NCT01160731

Sorafenib. ICORG 06-41, V4

Phase 2

Completed

Conditions: Esophageal Cancer
Gastric Cancer

Interventions: Drug: sorafenib tosylate
Other: laboratory biomarker analysis

First Posted Date: 2010-07-08

Last Posted Date: 2014-12-31

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 54

Registration Number: NCT01158287

Locations: 🇮🇪
Cork University Hospital, Cork, Ireland
🇮🇪
Waterford Regional Hospital, Waterford, Ireland
🇮🇪
Mater Misericordiae University Hospital, Dublin, Ireland

and more 5 locations

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Completed

Conditions: Breast Cancer
Pancreatic Cancer
Colorectal Cancer
Lung Cancer
Melanoma (Skin)

First Posted Date: 2009-09-10

Last Posted Date: 2017-05-24

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 803

Registration Number: NCT00974610

Locations: 🇮🇪
Mater Private Hospital, Dublin, Ireland
🇮🇪
Mid-Western Cancer Centre at Mid-Western Regional Hospital, Limerick, Ireland
🇮🇪
Cork University Hospital, Cork, Ireland

and more 10 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy